Transcatheter Aortic Valve Replacement Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031

Description

Persistence Market Research has recently published a comprehensive report on the global Transcatheter Aortic Valve Replacement (TAVR) Market, offering an in-depth analysis of key market dynamics such as drivers, opportunities, challenges, and trends. The report provides valuable insights into the structure and future prospects of the market.

Key Insights:

Transcatheter Aortic Valve Replacement Market Size (2024E): USD 5.64 Bn
Projected Market Value (2031F): USD 10.5 Bn
Global Market Growth Rate (CAGR 2024 to 2031): 6.5%

Transcatheter Aortic Valve Replacement Market - Report Scope:

The TAVR market focuses on the transcatheter-based procedure for replacing damaged aortic valves, particularly for patients who are at high or intermediate risk during traditional open-heart surgeries. This market is expanding rapidly due to advancements in valve technology and minimally invasive techniques. The increased adoption of TAVR procedures is being witnessed in hospitals, specialized cardiac centers, and clinics worldwide, driven by the aging population and the rising prevalence of cardiovascular diseases.

Market Growth Drivers:

The global TAVR market is primarily driven by the expanding indications for TAVR procedures, particularly for low-risk patients. The development of flexible and advanced delivery systems has enabled smoother and safer implantation procedures. Continuous innovation in valve materials and enhancements in valve durability are further supporting market growth. Additionally, the increasing aging population and the high prevalence of aortic stenosis contribute to the growing demand for TAVR procedures.

Market Restraints:

While the TAVR market shows promising growth, several challenges impede its full potential. High costs of TAVR devices and procedures, coupled with the complex regulatory landscape, particularly in emerging markets, present significant barriers. Additionally, a lack of skilled professionals in certain regions to perform these highly specialized procedures limits broader market adoption. Concerns over long-term valve durability in low-risk patients also pose challenges to market expansion.

Market Opportunities:

The TAVR market offers significant growth opportunities, especially in emerging markets with ongoing healthcare modernization efforts. Increasing healthcare expenditure and improving access to advanced treatments in regions like Asia-Pacific are creating lucrative opportunities for market players. Additionally, growing awareness of minimally invasive treatments and the rising preference for non-surgical options among the elderly population are boosting demand for TAVR procedures.

Key Questions Answered in the Report:

What are the key factors driving the TAVR market globally?
How is the market expanding in different healthcare settings?
Which technological innovations are shaping the future of TAVR procedures?
Who are the leading players in the market, and what strategies are they adopting to stay competitive?
What are the emerging trends in the global TAVR market?

Competitive Intelligence and Business Strategy:

Leading players in the global TAVR market are investing in research and development (R&D) to innovate advanced valve systems and delivery platforms. Companies are focusing on strategic partnerships with hospitals and specialized cardiac centers to increase the adoption of TAVR procedures. Significant emphasis is placed on consumer education and regulatory approvals, which play a critical role in the competitive landscape.

Key Market Players

Boston Scientific Corporation
Medtronic Plc
Abbott Laboratories
Anteris Technologies Ltd.
Coroneo Inc.
CryoLife Inc.
Edward Lifesciences Corporation
JenaValve Technology Inc.
LifeNet Health Inc.
LivaNova PLC
Thubrikar Aortic Valve Inc.

Transcatheter Aortic Valve Replacement Market Segmentation

By Procedure

Transfemoral Implantation
Transapical Implantation
Transaortic Implantation

By Mechanism

Self-Expanding
Balloon-expandable

By End User

Hospital
Ambulatory Surgical Centers
Others

By Region

North America
Europe
East Asia
South Asia and Oceania
Latin America
The Middle East and Africa

Product Code: PMRREP34740

1. Executive Summary

1.1. Global Transcatheter Aortic Valve Replacement Market Snapshot, 2024-2031
1.2. Market Opportunity Assessment, 2024-2031, US$ Bn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. PMR Analysis and Recommendations

2. Market Overview

2.1. Market Scope and Definition
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Opportunity
- 2.2.4. Challenges
- 2.2.5. Key Trends
2.3. Transcatheter Aortic Valve Replacement Adoption / Usage Analysis, By Region
2.4. PESTLE Analysis
2.5. Key Regulations by Region
2.6. Porter Five Force's Analysis
2.7. Macro-Economic Factors
- 2.7.1. Global Sectorial Outlook
- 2.7.2. Global GDP Growth Outlook
- 2.7.3. Global Parent Market Overview

3. Price Trend Analysis, 2019-2031

3.1. Key Highlights
3.2. Key Factors Impacting Procedure Prices
3.3. Prices By Procedure
3.4. Regional Prices and Procedure Preferences

4. Global Transcatheter Aortic Valve Replacement Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

4.1. Key Highlights
- 4.1.1. Market Value (US$ in Bn) Projections
- 4.1.2. Market Size and Y-o-Y Growth
- 4.1.3. Absolute $ Opportunity
4.2. Market Size (US$ Bn) Analysis and Forecast
- 4.2.1. Historical Market Size Analysis, 2019-2023
- 4.2.2. Current Market Size Forecast, 2023-2031
4.3. Global Transcatheter Aortic Valve Replacement Market Outlook: Procedure
- 4.3.1. Introduction / Key Findings
- 4.3.2. Historical Market Size (US$ Bn) and Volume (Units) and Analysis by Procedure, 2019-2023
- 4.3.3. Current Market Size (US$ Bn) and Volume (Units) Forecast by Procedure, 2024-2031
  - 4.3.3.1. Transfemoral Implantation
  - 4.3.3.2. Transapical Implantation
  - 4.3.3.3. Transaortic Implantation
4.4. Market Attractiveness Analysis: Procedure
4.5. Global Transcatheter Aortic Valve Replacement Market Outlook: Mechanism
- 4.5.1. Introduction / Key Findings
- 4.5.2. Historical Market Size (US$ Bn) Analysis by Mechanism, 2019-2023
- 4.5.3. Current Market Size (US$ Bn) Forecast by Mechanism, 2024-2031
  - 4.5.3.1. Self-Expanding
  - 4.5.3.2. Balloon-Expandable
4.6. Market Attractiveness Analysis: Mechanism
4.7. Global Transcatheter Aortic Valve Replacement Market Outlook: End-use
- 4.7.1. Introduction / Key Findings
- 4.7.2. Historical Market Size (US$ Bn) Analysis by End-use, 2019-2023
- 4.7.3. Current Market Size (US$ Bn) Forecast by End-use, 2024-2031
  - 4.7.3.1. Hospital
  - 4.7.3.2. Ambulatory Surgical Centers
  - 4.7.3.3. Others
4.8. Market Attractiveness Analysis: End-use

5. Global Transcatheter Aortic Valve Replacement Market Outlook: Region

5.1. Key Highlights
5.2. Historical Market Size (US$ Bn) Analysis by Region, 2019-2023
5.3. Current Market Size (US$ Bn) Forecast by Region, 2024-2031
- 5.3.1. North America
- 5.3.2. Europe
- 5.3.3. Asia Pacific
- 5.3.4. Latin America
- 5.3.5. Middle East & Africa
5.4. Market Attractiveness Analysis: Region

6. North America Transcatheter Aortic Valve Replacement Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

6.1. Key Highlights
6.2. Historical Market Size (US$ Bn) Analysis by Market, 2019-2023
- 6.2.1. By Country
- 6.2.2. By Procedure
- 6.2.3. By Mechanism
- 6.2.4. By End-use
6.3. Current Market Size (US$ Bn) Forecast by Country, 2024-2031
- 6.3.1. U.S.
- 6.3.2. Canada
6.4. Current Market Size (US$ Bn) and Volume (Units) Forecast by Procedure, 2024-2031
- 6.4.1. Transfemoral Implantation
- 6.4.2. Transapical Implantation
- 6.4.3. Transaortic Implantation
6.5. Current Market Size (US$ Bn) Forecast by Mechanism, 2024-2031
- 6.5.1. Self-Expanding
- 6.5.2. Balloon-expandable
6.6. Current Market Size (US$ Bn) Forecast by End-use, 2024-2031
- 6.6.1. Hospital
- 6.6.2. Ambulatory Surgical Centers
- 6.6.3. Dental Clinics
6.7. Market Attractiveness Analysis

7. Europe Transcatheter Aortic Valve Replacement Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

7.1. Key Highlights
7.2. Historical Market Size (US$ Bn) Analysis by Market, 2019-2023
- 7.2.1. By Country
- 7.2.2. By Procedure
- 7.2.3. By Mechanism
- 7.2.4. By End-use
7.3. Current Market Size (US$ Bn) Forecast by Country, 2024-2031
- 7.3.1. Germany
- 7.3.2. Italy
- 7.3.3. France
- 7.3.4. U.K.
- 7.3.5. Turkey
- 7.3.6. Russia
- 7.3.7. Rest of Europe
7.4. Current Market Size (US$ Bn) and Volume (Units) Forecast by Procedure, 2024-2031
- 7.4.1. Transfemoral Implantation
- 7.4.2. Transapical Implantation
- 7.4.3. Transaortic Implantation
7.5. Current Market Size (US$ Bn) Forecast by Mechanism, 2024-2031
- 7.5.1. Self-Expanding
- 7.5.2. Balloon-expandable
7.6. Current Market Size (US$ Bn) Forecast by End-use, 2024-2031
- 7.6.1. Hospital
- 7.6.2. Ambulatory Surgical Centers
- 7.6.3. Dental Clinics
7.7. Market Attractiveness Analysis

8. Asia Pacific Transcatheter Aortic Valve Replacement Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

8.1. Key Highlights
8.2. Historical Market Size (US$ Bn) Analysis by Market, 2019-2023
- 8.2.1. By Country
- 8.2.2. By Procedure
- 8.2.3. By Mechanism
- 8.2.4. By End-use
8.3. Current Market Size (US$ Bn) Forecast by Country, 2024-2031
- 8.3.1. China
- 8.3.2. Japan
- 8.3.3. South Korea
- 8.3.4. India
- 8.3.5. Southeast Asia
- 8.3.6. Rest of Asia Pacific
8.4. Current Market Size (US$ Bn) and Volume (Units) Forecast by Procedure, 2024-2031
- 8.4.1. Transfemoral Implantation
- 8.4.2. Transapical Implantation
- 8.4.3. Transaortic Implantation
8.5. Current Market Size (US$ Bn) Forecast by Mechanism, 2024-2031
- 8.5.1. Self-Expanding
- 8.5.2. Balloon-expandable
8.6. Current Market Size (US$ Bn) Forecast by End-use, 2024-2031
- 8.6.1. Hospital
- 8.6.2. Ambulatory Surgical Centers
- 8.6.3. Dental Clinics
8.7. Market Attractiveness Analysis

9. Latin America Transcatheter Aortic Valve Replacement Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

9.1. Key Highlights
9.2. Historical Market Size (US$ Bn) Analysis by Market, 2019-2023
- 9.2.1. By Country
- 9.2.2. By Procedure
- 9.2.3. By Mechanism
- 9.2.4. By End-use
9.3. Current Market Size (US$ Bn) Forecast by Country, 2024-2031
- 9.3.1. Brazil
- 9.3.2. Mexico
- 9.3.3. Argentina
- 9.3.4. Rest of Latin America
9.4. Current Market Size (US$ Bn) and Volume (Units) Forecast by Procedure, 2024-2031
- 9.4.1. Transfemoral Implantation
- 9.4.2. Transapical Implantation
- 9.4.3. Transaortic Implantation
9.5. Current Market Size (US$ Bn) Forecast by Mechanism, 2024-2031
- 9.5.1. Self-Expanding
- 9.5.2. Balloon-expandable
9.6. Current Market Size (US$ Bn) Forecast by End-use, 2024-2031
- 9.6.1. Hospital
- 9.6.2. Ambulatory Surgical Centers
- 9.6.3. Dental Clinics
9.7. Market Attractiveness Analysis

10. Middle East & Africa Transcatheter Aortic Valve Replacement Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

10.1. Key Highlights
10.2. Historical Market Size (US$ Bn) Analysis by Market, 2019-2023
- 10.2.1. By Country
- 10.2.2. By Procedure
- 10.2.3. By Mechanism
- 10.2.4. By End-use
10.3. Current Market Size (US$ Bn) Forecast by Country, 2024-2031
- 10.3.1. GCC Countries
- 10.3.2. South Africa
- 10.3.3. Egypt
- 10.3.4. Nigeria
- 10.3.5. Rest of Middle East and Africa
10.4. Current Market Size (US$ Bn) and Volume (Units) Forecast by Procedure, 2024-2031
- 10.4.1. Transfemoral Implantation
- 10.4.2. Transapical Implantation
- 10.4.3. Transaortic Implantation
10.5. Current Market Size (US$ Bn) Forecast by Mechanism, 2024-2031
- 10.5.1. Self-Expanding
- 10.5.2. Balloon-expandable
10.6. Current Market Size (US$ Bn) Forecast by End-use, 2024-2031
- 10.6.1. Hospital
- 10.6.2. Ambulatory Surgical Centers
- 10.6.3. Dental Clinics
10.7. Market Attractiveness Analysis

11. Competition Landscape

11.1. Market Share Analysis, 2023
11.2. Market Structure
- 11.2.1. Competition Intensity Mapping by Market
- 11.2.2. Competition Dashboard
11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
- 11.3.1. Boston Scientific Corporation
  - 11.3.1.1. Overview
  - 11.3.1.2. Segments and Product
  - 11.3.1.3. Key Financials
  - 11.3.1.4. Market Developments
  - 11.3.1.5. Market Strategy
- 11.3.2. Medtronic Plc
- 11.3.3. Abbott Laboratories
- 11.3.4. Anteris Technologies Ltd.
- 11.3.5. Coroneo Inc.
- 11.3.6. CryoLife Inc.
- 11.3.7. Edward Lifesciences Corporation
- 11.3.8. JenaValve Technology Inc.
- 11.3.9. LifeNet Health Inc.
- 11.3.10. LivaNova PLC
- 11.3.11. Thubrikar Aortic Valve Inc.

12. Appendix

12.1. Research Methodology
12.2. Research Assumptions
12.3. Acronyms and Abbreviations